Advanced search
Publication Cover
Expert Review of Clinical Pharmacology Volume 13, 2020 - Issue 7
Submit an article Journal homepage
1,433
Views
6
CrossRef citations to date
0
Altmetric
Editorial

Modern approaches for the phenotyping of cytochrome P450 enzymes in children

G. Maglioccoa Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland;b Division of Clinical Pharmacology and Toxicology, Geneva University Hospitals, Geneva, SwitzerlandORCID Iconhttps://orcid.org/0000-0003-4352-5440View further author information
ORCID Icon &
Y. Daalic Faculty of Medicine, University of Geneva, Geneva, Switzerland;d Swiss Center for Applied Human Toxicology, Geneva, Switzerland;a Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland;b Division of Clinical Pharmacology and Toxicology, Geneva University Hospitals, Geneva, SwitzerlandCorrespondence[email protected]
View further author information
Pages 671-674 | Received 21 Jan 2020, Accepted 26 Mar 2020, Published online: 15 Jun 2020

References

  • Dunne J, Rodriguez WJ, Murphy MD, et al. Extrapolation of adult data and other data in pediatric drug-development programs. Pediatrics. 2011;128:e1242-1249.
  • Kearns GL, Abdel-Rahman SM, Alander SW, et al. Developmental pharmacology–drug disposition, action, and therapy in infants and children. N Engl J Med. 2003;349:1157–1167.
  • Zanger UM, Schwab M. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther. 2013;138:103–141.
  • Caudle KE, Sangkuhl K, Whirl‐Carrillo M, et al. Standardizing CYP2D6 genotype to phenotype translation: consensus recommendations from the clinical pharmacogenetics implementation consortium and Dutch pharmacogenetics working group. Clin Transl Sci. 2020;13:116–124.
  • Magliocco G, Rodieux F, Desmeules J, et al. Toward precision medicine in pediatric population using cytochrome P450 phenotyping approaches and physiologically based pharmacokinetic modeling. Pediatr Res. 2020;87:441–449.
  • Slanar O, Nobilis M, Kvetina J, et al. Miotic action of tramadol is determined by CYP2D6 genotype. Physiol Res. 2007;56:129–136.
  • Connelly MA, Brown JT, Kearns GL, et al. Pupillometry: a non-invasive technique for pain assessment in paediatric patients. Arch Dis Child. 2014;99:1125–1131.
  • Hohmann N, Haefeli WE, Mikus G. Use of microdose phenotyping to individualise dosing of patients. Clin Pharmacokinet. 2015;54:893–900.
  • van Groen BD, Vaes WH, Park BK, et al. Dose‐linearity of the pharmacokinetics of an intravenous [14C]midazolam microdose in children. Br J Clin Pharmacol. 2019;85:2332–2340.
  • el-Yazigi A, Shabib S, al-Rawithi S, et al. Salivary clearance and urinary metabolic pattern of caffeine in healthy children and in pediatric patients with hepatocellular diseases. J Clin Pharmacol. 1999;39:366–372.
  • Chen R, Zheng X, Hu P. CYP2D6 phenotyping using urine, plasma, and saliva metabolic ratios to assess the impact of CYP2D6*10 on interindividual variation in a Chinese population. Front Pharmacol. 2017;8:239.
  • Link B, Haschke M, Grignaschi N, et al. Pharmacokinetics of intravenous and oral midazolam in plasma and saliva in humans: usefulness of saliva as matrix for CYP3A phenotyping. Br J Clin Pharmacol. 2008;66:473–484.
  • Li H, Canet MJ, Clarke JD, et al. Pediatric cytochrome P450 activity alterations in nonalcoholic steatohepatitis. Drug Metab Dispos. 2017;45:1317–1325.
  • Bosilkovska M, Samer CF, Déglon J, et al. Geneva cocktail for cytochrome p450 and P-glycoprotein activity assessment using dried blood spots. Clin Pharmacol Ther. 2014;96:349–359.
  • Magliocco G, Thomas A, Desmeules J, et al. Phenotyping of human CYP450 enzymes by endobiotics: current knowledge and methodological approaches. Clin Pharmacokinet. 2019;58:1373–1391.
  • Tay-Sontheimer J, Shireman LM, Beyer RP, et al. Detection of an endogenous urinary biomarker associated with CYP2D6 activity using global metabolomics. Pharmacogenomics. 2014;15:1947–1962.
  • Ince I, Solodenko J, Frechen S, et al. Predictive pediatric modeling and simulation using ontogeny information. J Clin Pharmacol. 2019;59:S95–S103.
  • Houle D, Govindaraju DR, Omholt S. Phenomics: the next challenge. Nat Rev Genet. 2010;11:855–866.
  • Özdemir V. Phenomics 2.0: real-world real-time patient outcomes measured by the internet of pharmaceutical things. OMICS. 2020;24:119–121.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.